1
|
Carril Ajuria L, Naigeon M, Dalban C, Desnoyer A, Rioux-Leclercq N, Sautès-Fridman C, Meylan M, Vano Y, Beuselinck B, Chouaib S, de Oliveira C, Tantot F, Escudier B, Albiges L, Chaput N. 687P NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
2
|
Thenault R, Beuzit L, Rioux-Leclercq N, Khene ZE, Gasmi A, Peyronnet B, Bensalah K, Mathieu R. Improving intermediate risk classification of prostate cancer with radiomics features. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01304-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
3
|
Ouzaid I, Kammerer-Jacquet S, Khene Z, Ravaud A, Patard J, Bensalah K, Rioux-Leclercq N. Exploration des facteurs biologiques prédictifs de la progression après chirurgie dans le carcinome rénal à haut risque : résultats de la cohorte française des patients de l’essai randomisé S-TRAC. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
4
|
Bensalah K, Bigot P, Albiges L, Bernhard J, Bodin T, Boissier R, Correas J, Gimel P, Hetet J, Long J, Nouhaud F, Ouzaïd I, Rioux-Leclercq N, Méjean A. Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein. Prog Urol 2020; 30:S2-S51. [DOI: 10.1016/s1166-7087(20)30749-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
5
|
Khene ZE, Kokorian R, Peyronnet B, Edeline J, Decrevoisier R, Crouzet L, Rioux-Leclercq N, Laguerre B, Pracht M, Mathieu R, Bensalah K. Metastatic clear-cell renal cell carcinoma: Computed tomography texture analysis as predictive biomarkers of survival in patients treated with Nivolumab: NivoMics 01-Study. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33321-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
6
|
Sosa Marrero C, Acosta O, Castro M, Hernández A, Rioux-Leclercq N, Castelli J, Paris F, de Crevoisier R. Modélisation/simulation de prolifération tumorale et de réponse à la radiothérapie. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
7
|
Vano Y, Rioux-Leclercq N, Dalban C, Sautès-Fridman C, Bougoüin A, Chaput N, Chouaib S, Beuselinck B, Chevreau C, Gross-Goupil M, Negrier S, Laguerre B, Borchiellini D, Colina-Moreno I, Fridman W, Chabaud S, Tantot F, Barros Monteiro J, Escudier B, Albiges L. NIVOREN GETUG-AFU 26 translational study: CD8 infiltration and PD-L1 expression are associated with outcome in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz249.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Desnoyer A, Larive A, Drubay D, Lanoy E, Vano Y, Rioux-Leclercq N, Chouaib S, Beuselinck B, Tantot F, Escudier B, Chaput N, Albiges L. Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz249.068] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
9
|
Gatin L, Mghir AS, Mouton W, Laurent F, Ghout I, Rioux-Leclercq N, Tattevin P, Verdier MC, Cremieux AC. Colistin-containing cement spacer for treatment of experimental carbapenemase-producing Klebsiella pneumoniae prosthetic joint infection. Int J Antimicrob Agents 2019; 54:456-462. [PMID: 31319190 DOI: 10.1016/j.ijantimicag.2019.07.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Revised: 06/29/2019] [Accepted: 07/10/2019] [Indexed: 11/29/2022]
Abstract
Carbapenemase-producing Enterobacteriaceae (CPE) are emerging multidrug-resistant bacteria responsible for invasive infections, including prosthetic joint infections (PJIs). Local administration of colistin may provide bactericidal concentrations in situ. This study evaluated the efficacy of a colistin-impregnated cement spacer, alone and in combination with systemic antibiotics, in a rabbit model of CPE-PJI. Elution of 3 MIU of colistimethate sodium (CMS) in 40 g of poly(methyl methacrylate) cement was studied in vitro. In vivo, 5 × 108 CFU of KPC-producing Klebsiella pneumoniae (colistin and meropenem MICs of 1 mg/L and 4 mg/L, respectively) were injected close to a prosthetic knee. Surgical debridement and prosthesis removal were performed 7 days later, and rabbits were assigned to six treatment groups (11-13 rabbits each): drug-free spacer; colistin-loaded spacer; colistin intramuscular (i.m.); colistin i.m. + colistin spacer; colistin i.m. + meropenem subcutaneous (s.c.); and colistin i.m. + meropenem s.c. + colistin spacer. Systemic treatment was administered at doses targeting pharmacokinetics in humans, and rabbits were euthanised 7 days later to evaluate bacterial counts in infected bones. In vitro, CMS elution was low (<0.1% at 24 h) but reached a local concentration of ≥20 mg/L (>20 × MIC). In vivo, combinations of local and systemic colistin, with or without meropenem, were the only regimens superior to the control group (P ≤ 0.05) in terms of viable bacterial counts and the proportion of rabbits with sterile bone, with no emergence of colistin-resistant strains. Colistin-loaded cement spacer in combination with systemic antibiotics were the most effective regimens in this CPE-PJI model.
Collapse
Affiliation(s)
- L Gatin
- UMR U1173 Université Versailles St-Quentin, Versailles, France; Service d'Orthopédie et traumatologie, Hôpital Raymond Poincaré, Garches, France
| | - A Saleh Mghir
- UMR U1173 Université Versailles St-Quentin, Versailles, France
| | - W Mouton
- Laboratoire de Bactériologie, Hôpital de la Croix Rousse, Centre National de Référence des Staphylocoques Unité Inserm 851, Faculté de Médecine Lyon Est, Lyon, France
| | - F Laurent
- Laboratoire de Bactériologie, Hôpital de la Croix Rousse, Centre National de Référence des Staphylocoques Unité Inserm 851, Faculté de Médecine Lyon Est, Lyon, France
| | - I Ghout
- URC Paris-Ouest, Laboratoire de Biostatistiques, Hôpital Ambroise Paré, Boulogne-Billancourt, France
| | - N Rioux-Leclercq
- Service d'Anatomopathologie, Hôpital Pontchaillou, CHU de Rennes, Rennes, France
| | - P Tattevin
- Service de Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, CHU de Rennes, 2 rue Henri Le Guilloux, 35033 Rennes Cedex, France.
| | - M C Verdier
- Laboratoire de Pharmacologie Biologique, Hôpital Pontchaillou, CHU de Rennes, Rennes, France
| | - A C Cremieux
- UMR U1173 Université Versailles St-Quentin, Versailles, France; Service des maladies infectieuses Hôpital Saint Louis AP-HP, Université Paris 7, Paris, France
| |
Collapse
|
10
|
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Grünwald V, Gillessen S, Horwich A. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 2019; 30:706-720. [PMID: 30788497 DOI: 10.1093/annonc/mdz056] [Citation(s) in RCA: 629] [Impact Index Per Article: 125.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/09/2023] Open
Affiliation(s)
- B Escudier
- Department of Medical Oncology, Gustave Roussy, Villejuif, France
| | - C Porta
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
| | - M Schmidinger
- Department of Medicine I, Clinical Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - N Rioux-Leclercq
- Department of Pathology, Rennes Hospital and University, Rennes, France
| | - A Bex
- UCL Division of Surgery and Interventional Science, Royal Free Hospital, Specialist Center for Kidney Cancer, London, UK; Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - V Khoo
- Department of Clinical Oncology, Institute of Cancer Research, Royal Marsden Hospital, London, UK; Department of Medicine, University of Melbourne and Monash University, Victoria, Australia
| | - V Grünwald
- Internal Medicine (Tumour Research) and Clinic for Urology, West German Cancer Center, University Hospital Essen, Essen, Germany
| | - S Gillessen
- Division of Cancer Sciences, University of Manchester, Manchester; The Christie, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St. Gallen, Switzerland
| | - A Horwich
- Department of Academic Radiotherapy, Institute of Cancer Research, Royal Marsden Hospital, Sutton Hospital, Sutton, UK
| |
Collapse
|
11
|
Boissier R, Ouzaid I, Nouhaud FX, Khene Z, Dariane C, Chkir S, Chelly S, Giwerc A, Allenet C, Lefrancq JB, Gimel P, Bodin T, Rioux-Leclercq N, Correas JM, Albiges L, Hetet JF, Bigot P, Bernhard JC, Long JA, Mejean A, Bensalah K. Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification. Int Urol Nephrol 2019; 51:951-958. [PMID: 30977021 DOI: 10.1007/s11255-019-02085-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2018] [Accepted: 01/17/2019] [Indexed: 10/27/2022]
Abstract
OBJECTIVES To evaluate the prognostic role of the Bosniak classification on the long-term oncological outcomes of cystic renal cell carcinomas. MATERIAL AND METHOD In a national multicentric retrospective study, we included patients treated surgically for localized cystic RCC from 2000 to 2010. Patients with a follow-up of less than 4 years, benign tumors, and ablative treatments were excluded. The primary outcome was disease-free survival. RESULTS 152 patients met the inclusion criteria: Bosniak II (6%), III (53%), IV (41%), with a median follow-up of 61 (12-179) months. Characteristics of the population and the tumors were [median, (min-max)] age 57 (25-84) years old, tumor size 43 mm (20-280), RENAL score 7 (4-12), PADUA score 8 (5-14). Treatments were 55% partial nephrectomy, 45% radical nephrectomy, 74% open surgery, and 26% laparoscopy. In pathological report, cystic RCC were mainly of low grade (1-2, 77%) and low stage (pT1, 81%). The two main histological subtypes were conventional (56%) and papillary (23%) RCC. Staging at presentation and histological characteristics were similar between Bosniak III and IV, except for high grade which was more common in Bosniak IV (12 vs 36%, p < 0.01). The Bosniak classification was not predictive of the recurrence, as 5- and 10-year disease-free survival were similar in Bosniak III and IV (92% vs 92% and 84% vs 83%, p = 0.60). CONCLUSION The Bosniak classification is predictive of the risk of malignancy but not of the oncological prognosis. Regardless of the initial Bosniak categories, almost all cystic RCCs were of low stage/grade and had low long-term recurrence rate.
Collapse
Affiliation(s)
- R Boissier
- Department of Urology and Kidney Transplantation, Conception Academic Hospital, Aix-Marseille University, 13005, Marseille, France.
| | - I Ouzaid
- Urology Department, Bichat-Claude-Bernard, Paris, France
| | - F X Nouhaud
- Urology Department, Rouen University Hospital, Rouen, France
| | - Z Khene
- Urology Department, Rennes University Hospital, Rennes, France
| | - C Dariane
- Urology Department, Georges Pompidou University Hospital, Paris, France
| | - S Chkir
- Department of Urology and Kidney Transplantation, Conception Academic Hospital, Aix-Marseille University, 13005, Marseille, France
| | - S Chelly
- Urology Department, Angers University Hospital, Angers, France
| | - A Giwerc
- Urology Department, Rouen University Hospital, Rouen, France
| | - C Allenet
- Urology Department, Bordeaux University Hospital, Bordeaux, France
| | - J B Lefrancq
- Urology Department, Grenoble University Hospital, La Tronche, France
| | - P Gimel
- Urology Department, Medipole, Cabestany, France
| | - T Bodin
- Urology Department, Saint-Joseph Hospital, Marseille, France
| | - N Rioux-Leclercq
- Pathology Department, Rennes University Hospital, Rennes, France
| | - J M Correas
- Radiology Department, Georges Pompidou University Hospital, Paris, France
| | - L Albiges
- Oncology Department, Gustave Roussy Institute, Paris, France
| | - J F Hetet
- Urology Department, Clinique Jules Verne, Nantes, France
| | - P Bigot
- Urology Department, Angers University Hospital, Angers, France
| | - J C Bernhard
- Urology Department, Bordeaux University Hospital, Bordeaux, France
| | - J A Long
- Urology Department, Grenoble University Hospital, La Tronche, France
| | - A Mejean
- Urology Department, Georges Pompidou University Hospital, Paris, France
| | - K Bensalah
- Urology Department, Rennes University Hospital, Rennes, France
| | | |
Collapse
|
12
|
Thibaud V, Rioux-Leclercq N, Vigneau C, Morice S. Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report. BMC Nephrol 2019; 20:6. [PMID: 30621605 PMCID: PMC6323659 DOI: 10.1186/s12882-018-1197-6] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2018] [Accepted: 12/26/2018] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Goodpasture Syndrome (GS) is an autoimmune disease caused by the development of auto-antibodies against the Glomerular Basement Membrane (GBM). Linear deposit of immunoglobulins G on the GBM detected by immunofluorescence analysis of renal biopsies is a GS pathognomonic finding. GS is commonly monophasic and its incidence is 1.6 case per million per year. CASE PRESENTATION This report describes and discusses the case of a 40-year-old woman who one year after allograft kidney transplant, presented with acute pulmonary and renal symptoms of GS, leading to acute graft dysfunction, without circulating anti-GBM antibody detection in laboratory assays. She received a living donor kidney transplant 4 years after the first diagnosis of GS without circulating anti-GBM antibodies, when considered in remission. CONCLUSIONS In both episodes, the diagnosis of GS was based exclusively on the kidney biopsy that showed rapidly progressing glomerulonephritis with deposition of immunoglobulins G on the GBM. Although rare, the management of patients with GS without circulating anti-GBM antibodies is difficult due to the lack of standardized follow-up guidelines to reduce the risk of GS recurrence after kidney transplantation.
Collapse
Affiliation(s)
- V Thibaud
- Department of Hematology, CHU Rennes, Rennes, France
| | | | - C Vigneau
- Department of Nephrology, CHU Rennes, Rennes, France
| | - S Morice
- Department of Nephrology, CHU Rennes, Rennes, France
| |
Collapse
|
13
|
Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, Boissier R, Correas JM, Gimel P, Hetet JF, Long JA, Nouhaud FX, Ouzaïd I, Rioux-Leclercq N, Méjean A. Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : prise en charge du cancer du rein. Prog Urol 2018; 28 Suppl 1:R5-R33. [DOI: 10.1016/j.purol.2019.01.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Accepted: 09/15/2018] [Indexed: 12/15/2022]
|
14
|
Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, Boissier R, Correas JM, Gimel P, Hetet JF, Long JA, Nouhaud FX, Ouzaïd I, Rioux-Leclercq N, Méjean A. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : prise en charge du cancer du reinFrench ccAFU guidelines – Update 2018–2020: Management of kidney cancer. Prog Urol 2018; 28:S3-S31. [PMID: 30473002 DOI: 10.1016/j.purol.2018.09.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Accepted: 09/15/2018] [Indexed: 12/15/2022]
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
Cet article est retiré de la publication à la demande des auteurs car ils ont apporté des modifications significatives sur des points scientifiques après la publication de la première version des recommandations.
Le nouvel article est disponible à cette adresse: DOI:10.1016/j.purol.2019.01.004.
C’est cette nouvelle version qui doit être utilisée pour citer l’article.
This article has been retracted at the request of the authors, as it is not based on the definitive version of the text because some scientific data has been corrected since the first issue was published.
The replacement has been published at the DOI:10.1016/j.purol.2019.01.004.
That newer version of the text should be used when citing the article.
Collapse
Affiliation(s)
- K Bensalah
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital Pontchaillou, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35033, Rennes cedex, France.
| | - L Albiges
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Département d'oncologie génito-urinaire, Gustave-Roussy, 94805, Villejuif cedex, France
| | - J-C Bernhard
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie et transplantation rénale, CHU de Bordeaux, place Amélie-Raba-Léon, 33076, Bordeaux, France
| | - P Bigot
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, CHU d'Angers, 4, rue Larrey, 49000, Angers, France
| | - T Bodin
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Centre d'urologie Prado-Louvain, 188, rue du Rouet, 13008, Marseille, France
| | - R Boissier
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie et transplantation rénale, CHU Conception, 147, boulevard Baille, 13005, Marseille, France
| | - J-M Correas
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'imagerie médicale (radiologie), hôpital universitaire Necker-Enfants-malades, 149, rue de Sèvres, 75015, Paris, France
| | - P Gimel
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Centre d'urologie, site Médipôle, 5, avenue Ambroise-Croizat, 66330, Cabestany, France
| | - J-F Hetet
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service de chirurgie urologique, clinique Jules-Verne, 2-4, route de Paris, 44314, Nantes, France
| | - J-A Long
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service de chirurgie urologique et de la transplantation rénale, hôpital Michallon, CHU Grenoble, boulevard de la Chantourne, 38700, La Tronche, France
| | - F-X Nouhaud
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, CHU de Rouen, 1, rue de Germont, 76000, Rouen, France
| | - I Ouzaïd
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Clinique urologique, hôpital Bichat-Claude-Bernard, 46, rue Henri-Huchard, 75018, Paris, France
| | - N Rioux-Leclercq
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'anatomie et cytologie pathologiques, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033, Rennes cedex 9, France
| | - A Méjean
- Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital européen Georges-Pompidou, université Paris Descartes, AP-HP, 75015, Paris, France
| |
Collapse
|
15
|
Beuselinck B, Verbiest A, Couchy G, Job S, de Reyniès A, Caruso S, Verkarre V, Rioux-Leclercq N, Schöffski P, Vano Y, Elaidi RT, Lerut E, Albersen M, Oudard S, Zucman-Rossi J. Tumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy283.078] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
16
|
Negrier S, Rioux-Leclercq N, Ravaud A, Gravis G, Geoffrois L, Chevreau C, Rolland F, Blanc E, Segura-Ferlay C, Perol D, Gross Goupil M, Dermeche S, Flechon A, Albiges L, Escudier B. Efficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy283.079] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
17
|
Kammerer-Jacquet SF, Thierry S, Rioux-Leclercq N. Cancers du rein : évolution de la classification anatomopathologique. ONCOLOGIE 2018. [DOI: 10.3166/onco-2019-0025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Depuis la dernière classification OMS des tumeurs urogénitales en 2004, les progrès en pathologie moléculaire ont permis de démembrer un certain nombre de sous-types histologiques des tumeurs du rein avec des profils histologiques, phénotypiques et moléculaires différents. Cette revue a pour objectif de rappeler les dernières nouveautés concernant l’évolution de la classification OMS des tumeurs du rein et les facteurs pronostiques requis pour ces cancers.
Collapse
|
18
|
Balusson F, Scailteux LM, Nowak E, Vincendeau S, Rioux-Leclercq N, Oger E. Appariement des bases de données médico-administratives. À propos d’un cas d’usage « CANARI ». Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.01.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
19
|
Scailteux L, Balusson F, Nowak E, Vincendeau S, Rioux-Leclercq N, Oger E. Risque de cancer de la prostate de haut grade après 2 ans d’utilisation de 5-ARI dans le traitement de l’hyperthrophie bénigne de la prostate. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Beaumont M, Dagher J, Dugay F, Kammerer-Jacquet S, Becker E, Cornevin L, Jaillard S, Mathieu R, Chalmel F, Bensalah K, Rioux-Leclercq N, Belaud-Rotureau M. Étude comparative des profils génétiques des métastases de carcinomes rénaux à cellules claires. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Khene Z, Peyronnet B, Bosquet E, Lucas F, Pradère B, Fardoun T, Grafeille V, Rioux-Leclercq N, Verhoest G, Mathieu R, Bensalah K. L’effraction tumorale lors de la néphrectomie partielle robot-assistée a-t-elle un impact sur la récidive tumorale ? Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
22
|
Guandalino M, Soria J, Vedrine N, Guy L, Khene Z, Peyronnet B, Bosquet E, Freton L, Grafeille V, Pradere B, Verhoest G, Rioux-Leclercq N, Mathieu R. Plaies urétérales traitées chirurgicalement. Étude monocentrique rétrospective. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
Nouhaud F, Bernhard JC, Bigot P, Khene Z, Audenet F, Lang H, Bergerat S, Fromont G, Allory Y, Lindner V, Verkarre V, Daniel L, Méjean A, Rioux-Leclercq N, Bensalah K. Profils histologiques des tumeurs rénales kystiques et leur corrélation avec la classification de Bosniak : étude multicentrique Uro-CCR/CCAFU. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
24
|
Khene Z, Peyronnet B, Bosquet E, Pradere B, Tambwe R, Freton L, Grafeille V, Tondut L, Verhoest G, Rioux-Leclercq N, Romain M, Bensalah K. L’intuition clinique du chirurgien permet-elle de mieux prédire la morbidité périopératoire de la néphrectomie partielle robot-assistée que les scores morphométriques ? Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
25
|
Aubert V, Acosta O, Rioux-Leclercq N, Mathieu R, Commandeur F, De Crevoisier R. EP-1598: Modelisation of radiation response at various fractionation from histopathological prostate tumors. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32033-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
Fardoun T, Peyronnet B, Oger E, Verhoest G, Mathieu R, Khene Z, Pradere B, Alimi Q, Manunta A, Rioux-Leclercq N, Patard JJ, Kammerer-Jacquet SF, Bensalah K. [Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience]. Prog Urol 2017; 26:1163-1170. [PMID: 28279366 DOI: 10.1016/j.purol.2016.09.074] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2015] [Revised: 09/23/2016] [Accepted: 09/30/2016] [Indexed: 01/20/2023]
Abstract
INTRODUCTION The aim of this study was to assess the impact of the acquisition of a Da Vinci® robot on the use and outcomes of partial nephrectomy (PN). PATIENTS AND METHODS It was a single center retrospective study including 280 patients who underwent PN from January 2006 to May 2013. The number of PN, tumors and patients' characteristics and perioperative outcomes have been assessed over 3 periods defined according to the main surgical approach: 2006-2008 (open PN), 2008-2010 (laparoscopic PN) and 2010-2013 (robotic PN). RESULTS Over the study period, the surgical approach has changed significantly in favor of minimally-invasive surgery and especially robotic approach. The PN/nephrectomy rate has also evolved to a higher proportion of PN over radical nephrectomy (P=0.002). No significant difference was noted between the three periods in terms of tumor size but there was a higher rate of highly complex tumors (RENAL score≥10) during the last period (10.7%; 18.6% and 33.2%; P=0.04). Warm ischemia time increased from 2006-2008 to 2008-2010 (26 vs. 23minutes) but decreased thereafter during the robotic era (14.5minutes; P<0.001). Regarding postoperative outcomes, the only change was a decreased length of stay over time (P=0.003). CONCLUSION In this single center series, the robotic approach was associated with a spread of PN and with an improvement of nephron-sparing surgery outcomes. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- T Fardoun
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - B Peyronnet
- Service d'urologie, CHU de Rennes, 35000 Rennes, France.
| | - E Oger
- Service de pharmacologie, CHU de Rennes, 35000 Rennes, France
| | - G Verhoest
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - R Mathieu
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - Z Khene
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - B Pradere
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - Q Alimi
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - A Manunta
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - N Rioux-Leclercq
- Service d'anatomopathologie, CHU de Rennes, 35000 Rennes, France
| | - J-J Patard
- Service d'urologie, CHU Kremlin-Bicêtre, 94043 Le Kremlin-Bicêtre, France
| | | | - K Bensalah
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| |
Collapse
|
27
|
Thierry S, Kammerer-Jacquet SF, Dugay F, Berquet G, Couapel JP, Alimi Q, Bensalah K, Rioux-Leclercq N. [Oncocytoma with a thrombus into the renal vein: A case report]. Prog Urol 2016; 27:1-2. [PMID: 27889176 DOI: 10.1016/j.purol.2016.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 10/16/2016] [Accepted: 10/21/2016] [Indexed: 11/17/2022]
Affiliation(s)
- S Thierry
- Service d'anatomie et cytologie pathologiques, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France.
| | - S F Kammerer-Jacquet
- Service d'anatomie et cytologie pathologiques, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - F Dugay
- Service de cytogénétique et biologie cellulaire, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - G Berquet
- Service d'urologie, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - J P Couapel
- Service d'urologie, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - Q Alimi
- Service d'urologie, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - K Bensalah
- Service d'urologie, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - N Rioux-Leclercq
- Service d'anatomie et cytologie pathologiques, université de Rennes 1, CHU Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| |
Collapse
|
28
|
Khene Z, Peyronnet B, Bosquet E, Pradere B, Fardoun T, Berquet G, Chatenet M, Huet R, Verhoest G, Thoulouzan M, Vincendeau S, Manunta A, Mathieu R, Rioux-Leclercq N, Bensalah K. Influence du niveau d’expérience de l’interne sur les résultats péri- et postopératoire de la néphrectomie partielle robot assistée. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
29
|
Khene Z, Peyronnet B, Robert C, Mathieu R, Verhoest G, Vincendeau S, Manunta A, Rioux-Leclercq N, Raman J, Bensalah K. RENAL nephrometry score vs Mayo Adhesive Probability Score : une étude internationale multicentrique. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
30
|
Khene Z, Peyronnet B, Bosquet E, Robert C, Pradere B, Fardoun T, Mathieu R, Verhoest G, Vincendeau S, Manunta A, Rioux-Leclercq N, Bensalah K. Existe-t-il une corrélation entre le Mayo Adhesive Probability Score et les caractéristiques anatomopathologiques des tumeurs rénales opérées par néphrectomie partielle ? Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
31
|
Wirth GJ, Haitel A, Moschini M, Soria F, Klatte T, Hassler MR, Bensalah K, Briganti A, Karam JA, Lotan Y, Margulis V, Raman JD, Remzi M, Rioux-Leclercq N, Robinson BD, Rouprêt M, Wood CG, Shariat SF. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract. World J Urol 2016; 35:943-949. [PMID: 27730305 DOI: 10.1007/s00345-016-1946-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2016] [Accepted: 09/27/2016] [Indexed: 12/23/2022] Open
Abstract
PURPOSE This study aims to determine the significance of androgen receptor (AR) expression in urothelial carcinoma of the upper urinary tract (UTUC). METHODS AR expression was assessed on tissue microarrays containing specimens of 737 patients with UTUC who underwent radical nephroureterectomy with curative intent. AR expression was correlated with clinical and pathological tumor features as well as recurrence-free survival (RFS), cancer-specific survival (CSS) and overall survival (OS). RESULTS Overall, AR was expressed in 11 % of tumors. AR expression was significantly associated with tumor necrosis as well as sessile and multifocal tumor growth but not with RFS, CSS or OS. AR was detected nearly twice as often in tumors of the ureter than of the pelvicalyceal system (p = 0.005). Subgroup analyses showed that the significant associations of AR with unfavorable pathologic features were exclusively attributable to tumors located in the ureter. However, in both ureteral and pelvicalyceal tumors, AR status was independent of RFS, CSS and OS. CONCLUSIONS In this cohort of patients treated with RNU, AR expression was found in approximately 10 % of UTUCs, twice as often in ureteral than in pelvicalyceal tumors. While AR expression had no impact on postoperative prognosis, it was significantly associated with unfavorable pathologic features in ureteral tumors. Steroid hormone signaling might be relevant for future investigations of differences between ureteral and pelvicalyceal tumors.
Collapse
Affiliation(s)
- G J Wirth
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.,Division of Urology, Department of Surgery, Geneva University Hospital, Geneva, Switzerland
| | - A Haitel
- Department of Clinical Pathology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
| | - M Moschini
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.,Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy
| | - F Soria
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.,Division of Urology, Department of Surgical Sciences, University of Studies of Torino, Turin, Italy
| | - T Klatte
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.,Karl-Landsteiner Institute for Urology and Andrology, Vienna, Austria
| | - M R Hassler
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria
| | - K Bensalah
- Department of Urology, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - A Briganti
- Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy
| | - J A Karam
- Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Y Lotan
- Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - V Margulis
- Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - J D Raman
- Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA
| | - M Remzi
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria
| | - N Rioux-Leclercq
- Department of Pathology, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - B D Robinson
- Department of Pathology, Weill Cornell Medical College, New York, NY, USA
| | - M Rouprêt
- Academic Department of Urology, La Pitié-Salpetrière Hospital, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Pierre et Marie Curie, University Paris 6, Paris, France
| | - C G Wood
- Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - S F Shariat
- Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medizinische Universität Wien/Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .,Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. .,Department of Urology, Weill Cornell Medical College, New York, NY, USA.
| |
Collapse
|
32
|
Alimi Q, Peyronnet B, Kammerer-Jacquet SF, Lefevre M, Gires B, Mathieu R, Tondut L, Vincendeau S, Manunta A, Rioux-Leclercq N, Guille F, Bensalah K, Verhoest G. [Oncologic and perioperative outcomes of robot-assisted radical cystectomy: A single-center prospective series]. Prog Urol 2016; 26:538-46. [PMID: 27590100 DOI: 10.1016/j.purol.2016.07.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2016] [Revised: 07/03/2016] [Accepted: 07/22/2016] [Indexed: 11/18/2022]
Abstract
INTRODUCTION The aim of this study was to report perioperative and oncological outcomes of robot-assisted radical cystectomy (RARC) in a single-center series and to evaluate the impact of the experience on perioperative outcomes. METHODS Between March 2012 and January 2016, 41 patients underwent RARC associated with extended pelvic lymphadenectomy for muscle-invasive bladder cancer. All RARC included were performed by a single-surgeon in one center. Perioperative and oncological datas were collected prospectively. Recurrence-free (RFS), overall (OS) and cancer-specific survivals (CSS) were estimated using the Kaplan-Meier Method. The impact of the experience on perioperative data was estimated using Spearman's correlation test. RESULTS Mean age was 67,7years (±10.6). Most patients underwent neoadjuvant chemotherapy (73.2%). Mean operative time and mean estimated blood loss were respectively 319.5minutes (±85.3) and 662.5mL (±360.9). Eight patients needed perioperative blood transfusion (19.5%). Conversion to open surgery was necessary in 3 cases (7.3%). Ileal neobladder was performed in 26.8% of the cases (54.5% being performed intracorporeal), and non-continent urinary diversion in 73.2%. Mean nodal yield was 17.7 (±9.3). Positive surgical margins were observed in 1 patient (2.3%). Mean length of stay was 13.2 days (±9.8). Postoperative complication rate was 46,3%. After a median follow-up of 16months, estimated 2 year-OS and CSS were respectively 62 and 76.1%. Estimated 2-year RFS was 67.6%. Perioperative outcomes improved with experience with a significant decrease in operative time (P=0.04) and a significant increase of nodal yield (P=0.05). CONCLUSION In this single-center prospective study, satisfactory perioperative and oncological outcomes after RARC were observed despite the learning curve. Perioperative outcomes improved with surgeon's experience. Further studies are needed to confirm these findings. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- Q Alimi
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France.
| | - B Peyronnet
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | | | - M Lefevre
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - B Gires
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - R Mathieu
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - L Tondut
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - S Vincendeau
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - A Manunta
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | | | - F Guille
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - K Bensalah
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| | - G Verhoest
- Department of urology, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35000 Rennes, France
| |
Collapse
|
33
|
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Gruenvald V, Horwich A. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27:v58-v68. [DOI: 10.1093/annonc/mdw328] [Citation(s) in RCA: 368] [Impact Index Per Article: 46.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
|
34
|
Rioux-Leclercq N, Comperat E, Kammerer-Jacquet SF, Camparo P, Fromont G. [Pathological advances in renal, prostatic, bladder and testis neoplasia]. Prog Urol 2016; 26:477-83. [PMID: 27473787 DOI: 10.1016/j.purol.2016.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Revised: 05/03/2016] [Accepted: 06/03/2016] [Indexed: 10/21/2022]
Abstract
INTRODUCTION The ISUP (International Society of Urological Pathology) Consensus Conferences between 2012 and 2015 made recommendations regarding the classification, staging, prognostic factors of adult tumors from kidney, prostate, bladder and testis. The main points of these recommendations are highlighted in this article. MATERIALS AND METHODS This article is based on a systematic literature search by using different keywords "cancer, kidney, prostate, bladder, testis, pathology, classification" from Pubmed database. Only publications between 2012 and 2015 were retained. RESULTS The different Consensus conferences since 2012 in uropathology have provided international guidelines for the classification, grading and staging of tumors in kidney, bladder, prostate and testis. We identified in this article the main points of these new guidelines that are about to be published in the new 2016 WHO classification of urogenital tract tumors in adult. CONCLUSION New pathological guidelines in urogenital tumors have to be taken into account for a better diagnosis and therapy.
Collapse
Affiliation(s)
- N Rioux-Leclercq
- Service d'anatomie et cytologie pathologiques, CHU de Rennes, 35033 Rennes, France.
| | - E Comperat
- Service d'anatomie et cytologie pathologiques, hôpital La Pitié-Salpêtrière, Paris cedex 13, France
| | - S-F Kammerer-Jacquet
- Service d'anatomie et cytologie pathologiques, CHU de Rennes, 35033 Rennes, France
| | - P Camparo
- Laboratoire d'anatomie et cytologie pathologiques, 85054 Amiens, France
| | - G Fromont
- Service d'anatomie et cytologie pathologiques, CHU de Tours, 37044 Tours cedex 9, France
| | | |
Collapse
|
35
|
Khene Z, Peyronnet B, Robert C, Prader B, Rohou T, Mathieu R, Verhoest G, Rioux-Leclercq N, Karim B. La graisse péri-rénale est-elle plus importante que la tumeur elle-même ? Le MAP score prédit mieux la morbidité péri-opératoire que le RENAL score. Prog Urol 2015; 25:744-5. [DOI: 10.1016/j.purol.2015.08.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
36
|
Brunot A, Rioux-Leclercq N, Bensalah K, Verhoest G, Edeline J, Bellaud P, Viel R, Jouan F, Laguerre B, Kammerer-Jacquet SF. Overexpression of PD-1 and PD-L1 in renal cell carcinoma is associated with poor prognosis in metastatic patients treated with sunitinib. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv097.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
37
|
Peyronnet B, Alimi Q, Mathieu R, Laguerre B, Vauleon E, Vincendeau S, Manunta A, Guille F, Rioux-Leclercq N, Bensalah K, Verhoest G. Intérêt de la surveillance scannographique après cystectomie pour cancer. Prog Urol 2014; 24:808. [DOI: 10.1016/j.purol.2014.08.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
38
|
Mathieu R, Tibari Y, Verhoest G, Vincendeau S, Manunta A, Rioux-Leclercq N, Bensalah K. [Comparative study of histological results between resection and biopsy of the prostate]. Prog Urol 2014; 24:374-8. [PMID: 24821561 DOI: 10.1016/j.purol.2013.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2013] [Revised: 09/29/2013] [Accepted: 10/01/2013] [Indexed: 10/26/2022]
Abstract
PURPOSE To evaluate the histological correlation between transuretral resection chips and biopsy cores within a population of patients who underwent resection of prostate (TURP) and prostate biopsies (BPx). PATIENTS AND METHODS Clinical and tumoral data of 77 patients who had both procedures simultaneously or with a slight delay were collected. According to the presence of prostate cancer (Pca), 4 groups were defined: group 1 (TURP and BPx negative), group 2 (TURP positive, BPx negative), group 3 (TURP negative, BPx positive), group 4 (TURP and BPx positive). Means and proportions were compared using Anova and χ(2) test, respectively. RESULTS The patients were older in groups 3 and 4 (79 and 76 respectively, P=0.65). The PSA was higher in the groups 3 and 4 (64 and 55 ng/mL) than the groups 1 and 2 (10.6 et 16 respectively, P=0.23). The number of positive biopsy was higher in the group 4 than the group 3 (5.6 vs. 4.6, P<0.0001), the chips were more invaded in the group 4 than the group 2 (41% vs. 11% P<0.0001), the Gleason score at TURP was higher in the group 4 than the group 2 (7.5 vs. 6.2 P<0.0001). CONCLUSION Our study underlines that the Pca of transition and peripheral zones seems to have distinct characteristics. When chips of TURP and BPx were both invaded, it was due to an aggressive cancer. The decision to explore the peripheral zone in the case of positive TURP must take clinical context into consideration.
Collapse
Affiliation(s)
- R Mathieu
- Service d'urologie, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-Le-Guillou, 35000 Rennes, France.
| | - Y Tibari
- Service d'urologie, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-Le-Guillou, 35000 Rennes, France
| | - G Verhoest
- Service d'urologie, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-Le-Guillou, 35000 Rennes, France
| | - S Vincendeau
- Service d'urologie, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-Le-Guillou, 35000 Rennes, France
| | - A Manunta
- Service d'urologie, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-Le-Guillou, 35000 Rennes, France
| | - N Rioux-Leclercq
- Service d'anatomocytopathologie, CHU de Rennes, 35042 Rennes, France
| | - K Bensalah
- Service d'urologie, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-Le-Guillou, 35000 Rennes, France
| |
Collapse
|
39
|
Dugay F, Dagher J, Verhoest G, Henry C, Jaillard S, Arlot-Bonnemains Y, Bensalah K, Vigneau C, Rioux-Leclercq N, Belaud-Rotureau MA. [Cytogenetics profiles of renal carcinoma]. Morphologie 2014; 98:1-7. [PMID: 24656859 DOI: 10.1016/j.morpho.2014.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2013] [Accepted: 02/12/2014] [Indexed: 11/29/2022]
Abstract
Renal carcinomas are histologically and prognostically heterogeneous. Genomic as well as chromosomal studies of these tumors have permitted a better comprehension of molecular mechanisms implicated in their development and progression. The most frequent histological subtypes are characterized by recurrent cytogenetic abnormalities, such as the loss of the chromosome 3 short arm involving a VHL gene copy in clear cell renal carcinomas, or trisomies 7 and 17 in papillary renal cell carcinomas. New histological subtypes like renal carcinomas associated with Xp11.2 translocations have also been individualized. Besides diagnosis, some chromosomal aberrations like the loss of a short arm of chromosome 9 in different renal carcinoma histological subtypes have a worse prognostic impact. The identification of chromosomal shuffles contributes in backing histological diagnosis and in precising the individual prognosis of patients. This review describes chromosomal abnormalities associated to renal carcinomas and their impact for an accurate classification of these tumors and the evaluation of their prognosis.
Collapse
Affiliation(s)
- F Dugay
- Service de cytogénétique et biologie cellulaire, hôpital Pontchaillou, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France; UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France
| | - J Dagher
- Service d'anatomie et cytologie pathologiques, CHU de Rennes, 35000 Rennes, France; UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France
| | - G Verhoest
- Service d'urologie, CHU de Rennes, 35000 Rennes, France; UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France
| | - C Henry
- Service de cytogénétique et biologie cellulaire, hôpital Pontchaillou, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France
| | - S Jaillard
- Service de cytogénétique et biologie cellulaire, hôpital Pontchaillou, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France
| | - Y Arlot-Bonnemains
- UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France
| | - K Bensalah
- Service d'urologie, CHU de Rennes, 35000 Rennes, France
| | - C Vigneau
- Service de néphrologie, CHU de Rennes, 35000 Rennes, France; UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France
| | - N Rioux-Leclercq
- Service d'anatomie et cytologie pathologiques, CHU de Rennes, 35000 Rennes, France; UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France
| | - M-A Belaud-Rotureau
- Service de cytogénétique et biologie cellulaire, hôpital Pontchaillou, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France; UMR 6290 IGDR, cancer du rein-BIOSIT, faculté de médecine-Rennes, 35000 Rennes, France.
| |
Collapse
|
40
|
Verhoest G, Dolley-Hitze T, Jouan F, Bensalah K, Arlot-Bonnemains Y, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N, Vigneau C. Système rénine-angiotensine et cancers urologiques. Prog Urol 2014; 24:73-9. [DOI: 10.1016/j.purol.2013.09.010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2013] [Revised: 09/12/2013] [Accepted: 09/13/2013] [Indexed: 01/10/2023]
|
41
|
Verhoest G, Patard J, Oger E, Rioux-Leclercq N, Peyronnet B, Bessède T, Laguna P, Barwari K, Rigaud J, Roupret M, Coffin G, Bernhard J, Long J, Zisman A, Berger J, Paparel P, Maurin C, Lechevallier E, Bertini R, Ouzaid I, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez A, Bensalah K. Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study. Urol Oncol 2014; 32:28.e21-6. [DOI: 10.1016/j.urolonc.2012.10.003] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2012] [Revised: 10/04/2012] [Accepted: 10/05/2012] [Indexed: 11/27/2022]
|
42
|
Fardoun T, Chaste D, Oger E, Mathieu R, Peyronnet B, Rioux-Leclercq N, Verhoest G, Patard J, Bensalah K. Predictive factors of hemorrhagic complications after partial nephrectomy. Eur J Surg Oncol 2014; 40:85-9. [DOI: 10.1016/j.ejso.2013.11.006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2013] [Revised: 10/27/2013] [Accepted: 11/03/2013] [Indexed: 10/26/2022] Open
|
43
|
Patard JJ, Baumert H, Bensalah K, Bernhard JC, Bigot P, Escudier B, Grenier N, Hétet JF, Long JA, Méjean A, Paparel P, Richard S, Rioux-Leclercq N, Coloby P, Soulié M. Recommandations en onco-urologie 2013 du CCAFU: Cancer du rein. Prog Urol 2013; 23 Suppl 2:S177-204. [DOI: 10.1016/s1166-7087(13)70055-1] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
44
|
Fardoun T, Couapel J, Senhadji L, Rioux-Leclercq N, Quemener M, Vorng J, Lavastre O, Bensalah K. La spectroscopique optique : une technique innovante pour caractériser l’agressivité des tumeurs de vessie. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Mathieu R, Fromont G, Rioux-Leclercq N, Cathelineau X, Bensalah K, Guille F, Primig M, Chalmel F. Signature d’expression de la lignée germinale dans les adénocarcinomes prostatiques. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
46
|
Bigot P, Verhoest G, Lebdai S, Ammi M, Jacquet S, Bensalah K, Rioux-Leclercq N, Azzouzi A. Le TGFBI est un marqueur d’agressivité des carcinomes rénaux à cellules claires. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Peyronnet B, Tanguy L, Fardoun T, Mathieu R, Boudry G, Galland F, Guilhem I, Verhoest G, Rioux-Leclercq N, Bensalah K, Manunta A. Surrénalectomie laparoscopique pour métastase surrénalienne. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
48
|
Delreux A, Verhoest G, Mathieu R, Vigneau C, Rioux-Leclercq N, Bensalah K. La néphrectomie laparoscopique pour rein polykystique est faisable et reproductible. Prog Urol 2013; 23:394-8. [DOI: 10.1016/j.purol.2012.12.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 12/20/2012] [Accepted: 12/23/2012] [Indexed: 01/15/2023]
|
49
|
Chaste D, Couapel JP, Fardoun T, Vincendeau S, Mathieu R, Rioux-Leclercq N, Verhoest G, Bensalah K. Néphrectomie partielle robot-assistée versus néphrectomie partielle laparoscopique : expérience d’un centre français. Prog Urol 2013; 23:176-83. [DOI: 10.1016/j.purol.2012.09.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2012] [Revised: 09/10/2012] [Accepted: 09/19/2012] [Indexed: 01/20/2023]
|
50
|
Rolland A, Lavigne R, Dauly C, Calvel P, Kervarrec C, Freour T, Evrard B, Rioux-Leclercq N, Auger J, Pineau C. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum Reprod 2012; 28:199-209. [DOI: 10.1093/humrep/des360] [Citation(s) in RCA: 89] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|